F. Braun

Most-cited papers

1. Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma.

   A. Busse, A. Asemissen, Anika Nonnenmacher, F. Braun +7 more

   2011European Journal of Cancer62 citations

   Semantic Scholar

   Save

2. Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome

   F. Braun, P. Grabarczyk, Markus Möbs, F. Braun +8 more

   2011Leukemia59 citations Open access

   Semantic Scholar

   Save

3. Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome

   Katarzyna Iżykowska, G. Przybylski, C. Gand, F. Braun +8 more

   2017OncoTarget47 citations Open access

   Semantic Scholar

   Save

4. Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth Vaccination

   S. Hein, Ines Mhedhbi, T. Zahn, Catarina Sabino +8 more

   2022Vaccines17 citations Open access

   Semantic Scholar

   Save

5. Systemic Immune Tuning in Renal Cell Carcinoma: Favorable Prognostic Impact of TGF-&bgr;1 mRNA Expression in Peripheral Blood Mononuclear Cells

   A. Busse, A. Asemissen, Anika Nonnenmacher, S. Ochsenreither +7 more

   2011Journal of immunotherapy16 citations

   Semantic Scholar

   Save

6. In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response

   F. Braun, J. V. D. van den Brandt, S. Thomas, S. Lange +7 more

   2015PLoS ONE11 citations Open access

   Semantic Scholar

   Save

7. Identification of multiple complex rearrangements associated with deletions in the 6q23-27 region in Sézary syndrome.

   K. Iżykowska, M. Zawada, K. Nowicka, P. Grabarczyk +7 more

   2013Journal of Investigative Dermatology9 citations Open access

   Semantic Scholar

   Save

8. 685 BCL11B overexpression leads to DNA damage resistance and delayed cell cycle progression

   P. Grabarczyk, V. Naehse, M. Delin, G. Przybylski +6 more

   20100 citations

   Semantic Scholar

   Save